123 related articles for article (PubMed ID: 35798371)
1. "Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension." Mark Toshner, Colin Church, Lars Harbaum,
Eur Respir J; 2022 Jul; 60(1):. PubMed ID: 35798371
[No Abstract] [Full Text] [Related]
2. "Asthma and incident coronary heart disease: an observational and Mendelian randomisation study." C.A. Valencia-Hernández, F. Del Greco M, V. Sundaram,
Eur Respir J; 2024 Mar; 63(3):. PubMed ID: 38548275
[No Abstract] [Full Text] [Related]
3. "Cellular sources of interleukin-6 and associations with clinical phenotypes and outcomes in pulmonary arterial hypertension." Catherine E. Simpson, Jenny Y. Chen, Rachel L. Damico,
Eur Respir J; 2022 Apr; 59(4):. PubMed ID: 35484798
[No Abstract] [Full Text] [Related]
4. Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension.
Toshner M; Church C; Harbaum L; Rhodes C; Villar Moreschi SS; Liley J; Jones R; Arora A; Batai K; Desai AA; Coghlan JG; Gibbs JSR; Gor D; Gräf S; Harlow L; Hernandez-Sanchez J; Howard LS; Humbert M; Karnes J; Kiely DG; Kittles R; Knightbridge E; Lam B; Lutz KA; Nichols WC; Pauciulo MW; Pepke-Zaba J; Suntharalingam J; Soubrier F; Trembath RC; Schwantes-An TL; Wort SJ; Wilkins MR; Gaine S; Morrell NW; Corris PA;
Eur Respir J; 2022 Mar; 59(3):. PubMed ID: 34588193
[TBL] [Abstract][Full Text] [Related]
5. "Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD". Ariel A. Calderon, Colin Dimond, David F. Choy, Rajita Pappu, Michele A. Grimbaldeston, Divya Mohan and Kian Fan Chung.
Eur Respir Rev; 2023 Jun; 32(168):. PubMed ID: 37019459
[No Abstract] [Full Text] [Related]
6. "Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats." R. Dumitrascu, C. Kulcke, M. Königshoff,
Eur Respir J; 2021 Dec; 58(6):. PubMed ID: 34916252
[No Abstract] [Full Text] [Related]
7. "Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms." S. Malenfant, M. Lebret, É. Breton-Gagnon,
Eur Respir Rev; 2024 Jan; 33(171):. PubMed ID: 38355152
[TBL] [Abstract][Full Text] [Related]
8. "Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis." Nikhil Hirani, Alison C. MacKinnon, Lisa Nicol,
Eur Respir J; 2022 Apr; 59(4):. PubMed ID: 35422427
[No Abstract] [Full Text] [Related]
9. "Spatial transcriptomics for respiratory research and medicine." S. Curras-Alonso, J. Soulier, T. Walter,
Eur Respir J; 2023 Feb; 61(2):. PubMed ID: 36822638
[No Abstract] [Full Text] [Related]
10. "Lung cancer survival in Norway, 1997-2011: from nihilism to optimism." Yngvar Nilssen, Trond Eirik Strand, Lars Fjellbirkeland, Kristian Bartnes and Bjørn Møller. Eur Respir J 2016; 47: 275-287.
Eur Respir J; 2016 Apr; 47(4):1297. PubMed ID: 27037324
[No Abstract] [Full Text] [Related]
11. "The patient tells it! The importance of patient's quality of life perception in pulmonary arterial hypertension risk assessment." Silvia Ulrich and Ekkehard Grunig.
Eur Respir J; 2021 Mar; 57(3):. PubMed ID: 33767003
[No Abstract] [Full Text] [Related]
12. Progression and prognostic indicators of bronchial disease in children with sickle cell disease.
Williams SN; Nussbaum E; Yoonessi L; Morphew T; Randhawa I
Lung; 2014 Jun; 192(3):385-93. PubMed ID: 24699774
[TBL] [Abstract][Full Text] [Related]
13. "Compassionate use of delamanid in adults and children for drug-resistant tuberculosis: 5-year update." S. Ghosh, L. Breitscheidel, N. Lazarevic,
Eur Respir J; 2024 Jan; 63(1):. PubMed ID: 38237996
[No Abstract] [Full Text] [Related]
14. "Aberrant anti-viral response of natural killer cells in severe asthma." J. Devulder, C. Chenivesse, V. Ledroit,
Eur Respir J; 2024 Mar; 63(3):. PubMed ID: 38548273
[No Abstract] [Full Text] [Related]
15. "Age-related changes in plasma biomarkers and their association with mortality in COVID-19." E.H.A. Michels, B. Appelman, J. de Brabander,
Eur Respir J; 2024 Feb; 63(2):. PubMed ID: 38423593
[No Abstract] [Full Text] [Related]
16. "From pre-COPD to COPD: a Simple, Low cost and easy to IMplement (SLIM) risk calculator." M.J. Divo, C. Liu, F. Polverino,
Eur Respir J; 2023 Oct; 62(4):. PubMed ID: 37857431
[No Abstract] [Full Text] [Related]
17. "Pulmonary arterial hypertension in patients treated with interferon." Laurent Savale, Caroline Sattler, Sven Günther, David Montani, Marie-Camille Chaumais, Swanny Perrin, Xavier Jaïs, Andrei Seferian, Roland Jovan, Sophie Bulifon, Florence Parent, Gérald Simonneau, Marc Humbert and Olivier Sitbon. Eur Respir J 2014; 44: 1627-1634.
Eur Respir J; 2015 Dec; 46(6):1854. PubMed ID: 26621897
[No Abstract] [Full Text] [Related]
18. "Balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension: is Europe behind?" Irene M. Lang and Hiromi Matsubara.
Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31649150
[No Abstract] [Full Text] [Related]
19. Letter to the Editor, regarding Li L, Zhu X, Chen X, Gao J, Ding C, et al. Advances in targeted therapy for pulmonary arterial hypertension in children. Eur J Pediatr. 2022 Dec 17.
Beghetti M; Ivy D; Scott N; Machlitt-Northen S; Lukas MA
Eur J Pediatr; 2023 May; 182(5):2453-2454. PubMed ID: 36847876
[No Abstract] [Full Text] [Related]
20. "SFTA3, a novel protein of the lung: three-dimensional structure, characterisation and immune activation." M. Schicht, F. Rausch, S. Finotto,
Eur Respir J; 2024 Jan; 63(1):. PubMed ID: 38237999
[No Abstract] [Full Text] [Related]
[Next] [New Search]
